Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07160712 · ClinicalTrials.gov registry record · NA
Radicle Relief 24_RLN: A Study Assessing the Impact of Health and Wellness Products on Pain and Related Health Outcomes.
A NA study of Pain, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07160712: Completed NA study of Pain, sponsored by Radicle Science.
NCT07160712 is a NA study of Pain that has completed, run by Radicle Science. The registered enrollment target is 1,000 participants, above the 302-participant average among 374 other Pain trials with a reported enrollment target (231% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07160712, a NA study of Pain, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on pain and related health outcomes.
Primary Outcome
Difference in rates of change over time in pain collective score as assessed by a collective of PROMIS Pain Interference 6A, Neuropathic Pain 5A, Nociceptive Pain 5A, and Pain Intensity 1A (scale 16-90; with higher scores corresponding to greater pain)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Relief Product Placebo Control
- DIETARY_SUPPLEMENT Relief Active Product 1
- DIETARY_SUPPLEMENT Relief Active Product 2
- DIETARY_SUPPLEMENT Relief Active Product 3
Study Locations (1)
California
- Radicle Science Inc. - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-09-04 |
| Est. Completion | 2025-12-08 |
| Phase | NA |
What the finished NCT07160712 record still lists
NCT07160712 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 302-participant average among 374 other Pain trials with a reported enrollment target (231% higher).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Relief Product Placebo Control is the first listed.
NCT07160712 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07160712 about?
NCT07160712 is a clinical study titled "Radicle Relief 24_RLN: A Study Assessing the Impact of Health and Wellness Products on Pain and Related Health Outcomes.". A randomized, double-blind, placebo-controlled direct-to-consumer study assessing the impact of health and wellness products on pain and related health outcomes.
What is the current status of trial NCT07160712?
This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-09-04. Estimated completion is 2025-12-08.
What conditions does trial NCT07160712 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT07160712?
The interventions under investigation include: Relief Product Placebo Control (DIETARY_SUPPLEMENT), Relief Active Product 1 (DIETARY_SUPPLEMENT), Relief Active Product 2 (DIETARY_SUPPLEMENT), Relief Active Product 3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07160712?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07160712 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07160712's enrollment target sits among peer trials
1,000 13th of 374 higher than 360 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI